Lotto Max - The Tuesday, June 28 draw will offer a $70 million jackpot and an estimated 14 Maxmillions

·1 min read

MONTRÉAL, June 25, 2022 /CNW Telbec/ - Yesterday's Lotto Max draw saw 1  Maxmillions prize (worth $1 million each) awarded to a holder  of a selection  sold in Québec. In the Tuesday, June 28 draw, the prize pool will amount to $84 million and include a $70 million jackpot and an estimated 14 Maxmillions.

Lotto Max (CNW Group/Loto-Québec)
Lotto Max (CNW Group/Loto-Québec)

Lotto Max continues to churn out winners in Québec

  • Lotto Max players in Québec have won over $3.164 billion since its launch in 2009.

  • In total, there have been 39 jackpot wins in the province, including 3 of $70,000,000—the largest jackpots ever won in Québec—in the February 25 and October 9, 2020, and June 7 2022 draws.

  • One $65,000,000 jackpot, four $60,000,000 jackpots, four $55,000,000 jackpots, and seven $50,000,000 jackpots were also won in Quebec.

  • In addition to these jackpot wins, Lotto Max players in Québec have also won a total of 186 Maxmillions prizes, each worth $1 million, and 128 shares of Maxmillions prizes.

Draw results are available online at lotoquebec.com.

About Loto-Québec

Loto-Québec's mission is to responsibly and efficiently manage games of chance in a controlled and measured fashion in the interest of all Quebecers. Entertainment is at the heart of its activities. Between January 1 and June 19, 2022, Loto-Québec paid out 53 prizes of $1,000,000 or more to winners. The Gagnant à vie and Grande Vie lottery games have provided nine lucky winners with a lifetime annuity. Major prize winners are listed on the Winners page of the Lotteries website.

SOURCE Loto-Québec

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/25/c9308.html

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest Stories

  • AgroFresh Solutions Reports Results for Second Quarter and First Half of 2022

    Second quarter 2022 net sales were $25.8 million, an increase of 17.5% (or 23.9% on a constant currency basis) versus the prior year period; first half 2022 net sales increased 7.8% (or 12.1% on a constant currency basis) versus the prior year period.Diversification revenue (all other product categories excluding SmartFresh™ for apples) grew 12.0% for the trailing twelve month period ended June 30, 2022 versus the twelve months ended June 30, 2021, and represented 44.1% of consolidated revenues

  • How Sixt and Turo are addressing ongoing car rental shortages, skyrocketing prices in Canada

    Making the journey to an out-of-town event or vacation has been difficult but it’s not about COVID-19 restrictions, it’s due to persistent car rental shortages and skyrocketing prices in many places in Canada. Sixt and Turo are trying to fix some of those issues.

  • Bird Construction Inc. Announces 2022 Second Quarter Financial Results

    "Bird is operationally aligned to capitalize on new and emerging opportunities in the market given the breadth and depth of our service offerings and nationwide presence. Notwithstanding the current economic uncertainty, our bid pipeline remains healthy and we were able to secure new awards of $421 million in the second quarter", stated Teri McKibbon, President and CEO of Bird Construction. "The risk profile and collaborative nature of our project portfolio is well diversified, and will help the

  • Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Progress in STS101 Development Program

    - Completed enrollment in the SUMMIT pivotal Phase 3 efficacy trial of STS101, randomizing more than 1,400 subjects - - On track to announce SUMMIT trial topline results in Q4 2022 - - Completed STS101 clinical and CMC pre-NDA meetings with FDA - - Presented nine abstracts at major medical meetings highlighting STS101 and its differentiated profile - - $68.1 million in cash, cash equivalents and marketable securities as of June 30, 2022, provides runway into second half of 2023 - SOUTH SAN FRANC

  • AdTheorent Holding Company, Inc. Reports Second Quarter 2022 Results

    Revenue Increased 6.5% Lead By Strong Growth in CTV and Healthcare & Retail Verticals;Company Continues to Expand Predictive Capabilities of Privacy-Forward Media Buying Platform NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a programmatic digital advertising leader using advanced machine learning technology and privacy-forward solutions to deliver real-world value for advertisers and marketers, today announced second

  • MeridianLink® Reports Second Quarter 2022 Results

    COSTA MESA, Calif., August 09, 2022--MeridianLink, Inc. (NYSE: MLNK) today announced financial results for the second quarter ended June 30, 2022.

  • LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2022 Results on August 23, 2022

    SALT LAKE CITY, Aug. 09, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2022, after the stock market closes on Tuesday, August 23, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international ca

  • Seer Reports Second Quarter 2022 Financial Results

    Company launches novel proteogenomics workflow with the Proteograph™ Analysis Suite 2.0, further demonstrates the power of its technology with new customer data, and advances key partnershipsREDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2022. “We are building on a strong start to the year and I am pleased wit

  • OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

    Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in the validation of our value propositionGenerated $4.4 million in cash flow from operations during the first half of 2022 ROCHESTER, Mich., Aug. 09, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, reported results for t

  • BioAtla Reports Second Quarter 2022 Financial Results And Highlights Recent Progress

    Mecbotamab vedotin (BA3011) Phase 2 preliminary observations in Non-Small Cell Lung Carcinoma (NSCLC) supports advancing to the registrational stage of the study; anticipate full interim data set in 4Q22 Mecbotamab vedotin (BA3011) Undifferentiated Pleomorphic Sarcoma (UPS) and osteosarcoma Phase 2 part 2 enrollment anticipated to begin 4Q22 following requested written feedback from FDA; continuing to enroll additional cohorts Mecbotamab vedotin (BA3011) sarcoma Phase 2 top-line interim data sup

  • The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets

    Investment to accelerate Company’s expansion into new markets, bringing high-quality, value-based care to more patientsCERRITOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced entry into an agreement for the investment of $110 million from investment funds affiliated with Deerfield Management Company, L.P. (“Deerfield”), an investment firm committed to advancing h

  • Roblox Reports Second Quarter 2022 Financial Results

    SAN MATEO, Calif., August 09, 2022--Roblox Reports Second Quarter 2022 Financial Results

  • Ulcerative Colitis Therapeutics Market to Reach $12 Billion by 2027 – Arizton

    The U.S. accounted for the highest share of over 70% in the global ulcerative colitis therapeutics market due to rise in prevalence of ulcerative colitis, presence of key players, and rise in access to healthcare due to well-established healthcare infrastructure.Chicago, Aug. 09, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s latest research report, ulcerative colitis market is expected to grow a at CAGR of 8.7% during 2022-2027. With more than 150+ molecules in various stages of development, i

  • BBX Capital, Inc. Reports Financial Results For the Second Quarter of 2022

    FORT LAUDERDALE, Fla., August 09, 2022--BBX Capital, Inc. Reports Financial Results For the Second Quarter of 2022

  • Zai Lab Announces Second Quarter 2022 Financial Results and Corporate Updates

    Key pipeline milestones achieved including the BLA acceptance of efgartigimod by China’s NMPA and positive topline results for the KarXT Phase 3 EMERGENT-2 trial Continued revenue growth led by ZEJULA; strong balance sheet with a cash position of $1.26 billion Company to host a conference call and webcast on August 10, 2022, at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative,

  • Treace Medical Concepts Reports Second Quarter 2022 Financial Results

    PONTE VEDRA, Fla., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today reported financial results for the second quarter ended June 30, 2022. Recent Highlights: Revenue of $30.0 million in the second quarter 2022, a 45% increase over the same period last year. Blended average revenue per case increased 5%

  • TeraGo Adjusts Timing of Second Quarter 2022 Financial Investor Conference Call to Monday, August 15, 2022 at 10:00 a.m. ET

    TeraGo Inc. ("TeraGo" or the "Company") (TSX: TGO) (www.terago.ca), has adjusted the timing of its second quarter conference call from Thursday, August 11, 2022, at 10:00 a.m. Eastern time (7:00 a.m. Pacific time) to Monday, August 15, 2022 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time) due to additional time required to complete the accounting reconciliation requirements related to the Company's cloud & colocation business lines, which were divested to Hut 8 Mining Corp. on January 31, 202

  • Arcus Biosciences Announces New Employment Inducement Grants

    HAYWARD, Calif., August 09, 2022--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted nine new employees options to purchase a total of 22,100 shares of the Company’s common stock at an exercise price per share of $27.35, which was the closing price on August 8, 2022, and restricted stock units to acquire a total of 11,050 sh

  • Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

    CAMBRIDGE, Mass., August 09, 2022--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) ("Infinity" or the "Company"), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced its second quarter 2022 financial results, unveiled new positive data from the Phase 2 MARIO-275 clinical trial, and provided a business update.

  • XL Fleet Announces Second Quarter 2022 Financial Results

    WIXOM, Mich., August 09, 2022--XL Fleet Corp. (NYSE: XL) ("XL Fleet" or the "Company"), a leading provider of fleet electrification solutions and energy efficiency, today announced second quarter 2022 financial results.